| Primary information |
|---|
| ID | 13177 |
| Uniprot ID | P20068 |
| Description | Neurotensin/neuromedin N [Cleaved into- Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide] |
| Organism | Rattus norvegicus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires (Rodents and rabbits); Rodentia; Myomorpha (mice and others); Muroidea; Muridae; Murinae; Rattus; Rattus norvegicus (Rat) |
| Subcellular Location | Secreted Cytoplasmic vesicle; secretory vesicle. Note=Packaged within secretory vesicles. |
| Developmental Stage | NA |
| Similarity | Belongs to the neurotensin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Neurotensin may play an endocrine or paracrine role in the regulation of fat metabolism. It causes contraction of smooth muscle. |
| Length | 169 |
| Molecular Weight | 19 |
| Name | Neurotensin/neuromedin N |
| Sequence | KIPYIL |
| Sequence map | 144 |
| PDB ID | 2832414; 8471039; 8462460 |
| Drugpedia | 3ZEV;4BUO;4BV0;4BWB;4GRV;4XEE;4XES;5T04;7L0P;7L0Q; |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|